The European Medicines Agency has issued guidance on the information that companies should include in the package leaflet of medicines that use ethanol as an excipient to explain the potential effects of the substance in children. Sponsors of affected medicines have three years to update their product information.
Ethanol may be used as a solvent, preservative or a cutaneous penetration enhancer in medicines. Although human exposure to ethanol...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?